Objectives: Miniscrew has been frequently used, considering that anchorage control is a critical point in orthodontic treatment, and its failure, the main adverse problem. Using two groups of stable (successful) and unstable (failed) mini-implants, this in vivo study aimed to quantify proinflammatory cytokines IL-1α, IL-6, IL-17, and TNF-α and osteoclastogenesis marker RANK, RANKL, and OPG in gingival tissue, using the real-time polymerase chain reaction technique. Methodology: Thirteen patients of both sexes (11-49 years old) under orthodontic treatment were selected, obtaining 11 successful and 7 failed mini-implants. The mini-implants were placed and removed by the same surgeon, in both jaws. The mean time of permanence in the mouth was 29.4 months for successful and 7.6 months for failed mini-implants. At removal time, peri-mini-implant gingival tissue samples were collected and processed for quantification of the proinflammatory cytokines and osteoclastogenesis markers. Nonparametric Wilcoxon rank-sum test considering the clusters and Kruskal-Wallis test were used for statistical analysis (α=0.05). Results: No significant difference (p>0.05) was observed between the groups for either quantification of cytokines or osteoclastogenesis markers, except for IL-6 (p<0.05). Conclusions: It may be concluded that the expression of IL-1α, IL-17, TNF-α, RANK, RANKL, and OPG in peri-implant gingival tissue were not determinant for mini-implant stability loss, but the higher IL-6 expression could be associated with mini-implant failure.
Introduction
Mini-implants have been widely used in orthodontics 1,2 with a high clinical success rate. 3 Even so, loss of devices may still occur in some cases. The reasons for failures are not entirely clear. According to a recent revision, 4 failure was associated with initial loading, inadequate hygiene, brushing, or thrusting in the area, and persistent inflammation. Moreover, inflammation is frequently mentioned as one of the factors involved in implant loss. 3, 5, 6 The installation of dental implants promotes the activation of molecular mechanisms involved in bone remodeling for osteointegration and can also trigger a cascade of inflammatory reactions by the stimulus of cytokine and chemokine production, contributing to the establishment of a unique biochemical environment. [7] [8] [9] Moreover, inflammatory and immune response increases in peri-implant periodontal tissues with increased microbial colonization of implants after installation in the oral cavity, resulting in greater production of proinflammatory cytokines. 7, 10 The expression of these proinflammatory cytokines and osteoclastogenesis-related factors plays an important role in the development and severity of peri-implantitis, a major cause of dental implant loss. [11] [12] [13] A balance between pro-inflammatory and antiinflammatory cytokines regulates immune response.
These mediators are also key regulating factors of osteoclast and osteoblast differentiation and activation, which modulate osteoclastogenesis and maintain bone homeostasis, especially in response to aggressive agents. 7, 10 IL-1α and IL-6 have a trigger in osteoclast differentiation and proliferation, improving bone loss. TNF-α is released by lymphocytes, fibroblasts, leukocytes, and epithelial cells of the gingival tissue and has a key role in the inflammatory process by inducing the over-expression of the nuclear factor κB (Receptor Activator of Nuclear Factor Kappa-Β Ligand) 14,15 and, consequently, bone resorption. IL-17 is a proinflammatory cytokine, and its receptors are expressed by osteoclasts, osteoblasts, synoviocytes, and chondrocytes cells. IL-17 increases RANKL expression in osteoblasts cells, as well as TNF-α and IL-1 production in synovial macrophages. 16-18 RANK/ RANKL/OPG system is a key signaling molecules that facilitate cross-talk between osteoblasts and osteoclasts. OPG inhibits the binding of RANK to RANKL, thus inhibiting osteoclast recruitment, proliferation, and activation. Abnormalities in the balance of RANK/RANKL/OPG system increase bone resorption. 19, 20 Due to the scarcity of studies, it is not known whether cytokines can cause development of periimplantitis in orthodontic mini-implants as well. The evaluation of these mediators involved in inflammation is critical to increase the stability of temporary anchorage devices in orthodontics. 8 Only few studies evaluated the expression of some cytokines -IL-1 β, IL-2, IL-6, and IL-8 -in peri-implant crevicular fluid in response to orthodontic tooth movement, 21, 22 Significance level was set at 5%.
Results
Peri-implant gingival tissue samples of 18 miniimplants (7 failed and 11 successful) were obtained from 13 patients. Descriptive data analysis showed no statistically significant difference between the groups regarding age and gender. The only significant difference (p=0.0116) was the meantime of permanence in the mouth, as the successful miniimplants remained in the mouth for a significantly longer time than failed mini-implants ( Table 1 ).
Successful mini-implants

The comparison between the groups relative to
pro-inflammatory cytokine levels (IL-1α, IL-6, IL-17, and TNF-α) showed a significant difference only for IL-6 (p=0,0397) (Figure 1 ), significantly higher in failed mini-implants.
Diversely, comparison between the groups revealed no statistically significant difference (p>0.05) relative to osteoclastogenesis markers (RANK, RANKL, OPG) ( Figure 2 ). Medians of RANKL/OPG ratio were 0.2836 for successful mini-implants and 0.2278 for failed ones, without statistically significant difference between the groups (p>0.05).
Discussion
Pro-inflammatory and anti-inflammatory cytokines regulate osteoclast and osteoblast differentiation and activation, which modulate osteoclastogenesis and maintain bone homeostasis, especially in response to aggressive agents. 6, 7 Cytokine overexpression involved in inflammation is critical to increase the stability of temporary anchorage devices in orthodontics. 8 Inflammatory events are commonly identified as key elements of healing processes, inflammation mechanism remains unclear. 25 Then, this study evaluated the gene expression of cytokines and osteoclastogenese markers to verify their role in failed mini-implants.
In this study, no significant differences were found between successful and failed mini-implants regarding IL-1α expression in peri-implant gingival tissue samples of both groups, but the group with failed mini-implants showed higher numerical values of this cytokine than the one with successful mini-implants. Güncü, et al. 10 (2012) evaluated IL-1β expression in the peri-implant crevicular fluid of dental implants with healthy or inflamed peri-implant gingival tissues using enzyme immunoassay (ELISA) and found significantly higher IL-1β levels in the group with peri-implantitis. In this study, no significant differences were found between successful and failed mini-implants regarding IL-1α expression in the peri-implant gingival tissue samples of the two groups, but the group with failed mini-implants showed higher numerical values of this cytokine than the one with successful mini-implants.
Comparing both groups, difference was observed in IL-6 levels, with statistically higher levels in failed mini-implants. This result reinforces that this pro- implants with severe peri-implantitis, followed by initial peri-implantitis and mucositis, which did not differ from each other. Lowest values were found in healthy sites. However, no significant difference could be found between groups regarding TNF-α levels in this study with orthodontic mini-implants. This difference could be due to the good use of defined groups by Duarte, et al. 11 (2009) (implants with healthy tissues, mucositis, initial periimplantitis, and severe periimplantitis), while some degree of clinically detectable inflammation was often observed in this study, even in the successful mini-implants.
In orthodontics, RANK/RANKL/OPG system has been shown to play an important role in the bone remodeling process. In this study, no differences were observed between the groups regarding RANK, RANKL, and OPG levels. For RANKL, our results agree with those of Güncü, et al. 10 Although some authors suggest that inflammation of the mucosa adjacent to mini-implants, periimplantitis and even bone loss mediated by the host response can be decisive for mini-implant failure, 6, 8, 30 no other studies published quantified pro-inflammatory cytokines and osteoclastogenesis mediators in gingival Quantification of pro-inflammatory cytokines and osteoclastogenesis markers in successful and failed orthodontic mini-implants J Appl Oral Sci. 2019;27:e20180476 7/7 tissue surrounding successful and failed mini-implants, hindering a direct comparison with these results.
Conclusion
The expression of pro-inflammatory cytokines IL-1α, IL-17, and TNF-α and osteoclastogenesis markers RANK, RANKL, and OPG in peri-implant gingival tissue were not determinant for mini-implant stability loss. The higher expression of the IL-6 pro-inflammatory cytokine could be associated with mini-implant stability loss.
